Product Information
DROSPIRENONE-EE 3-0.02 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1895 per EA under NDC 68462072029. Its NADAC has been published 566 times since Oct 21, 2015.
FDA first approved this application on Aug 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462072029
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA204296FDA Approved
8/17/2015
TE Code
AB
On Market Since
8/17/2015
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has been published 566 times since Oct 21, 2015, and over the history we have for it it has declined 89.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $1.7851 (Jan 13, 2016) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.3784 |
| Average price | $0.5799 |
| Largest weekly change | +35.7% (Feb 21, 2018) |
| Weeks tracked | 566 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.02 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.02 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1895 per EA (NDC 68462072029), effective Aug 19, 2026.
How has the price of DROSPIRENONE-EE 3-0.02 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has declined 89.0%. It has been tracked across 566 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.02 MG TAB?
Since Oct 21, 2015, the NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $1.7851 (Jan 13, 2016), with a median of $0.3784 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.02 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSPIRENONE-EE 3-0.03 MG TAB, is $0.1492 per EA — about 21% below DROSPIRENONE-EE 3-0.02 MG TAB.
Who manufactures DROSPIRENONE-EE 3-0.02 MG TAB?
DROSPIRENONE-EE 3-0.02 MG TAB (NDC 68462072029) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.